Alcohol Use Disorders

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Alcohol Use Disorders is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

13/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

clinical trials

Completed12 · 80%

Withdrawn1 · 7%

Terminated1 · 7%

Recruiting1 · 7%

Clinical Trials

Trial Activity

15 trials

Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders

Recruiting·YYale University·Phase 2·NCT03764098·160 enrolled

[C-11]PiB PET Imaging in Alcohol Use Disorders

Completed·UUniversity of Pittsburgh·Phase 1·NCT03746366·39 enrolled

Treatment Strategy for Alcohol Use Disorders in Veterans With TBI

Completed·VVA Office of Research and Development·Phase 3·NCT01342549·62 enrolled

CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders

Completed·VVA Office of Research and Development·Phase 2·NCT02500602·144 enrolled

Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders

Completed·MMedical University of South Carolina·Phase 1·NCT03732248·21 enrolled

Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders

Completed·SSeattle Institute for Biomedical and Clinical Research·Phase 2·NCT02322047·31 enrolled

Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders

Completed·YYale University·Phase 2·NCT01000987·44 enrolled

The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders

Completed·YYale University·Phase 1·NCT03872128·91 enrolled

Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD

Completed·SSeattle Institute for Biomedical and Clinical Research·N/A·NCT02226367·158 enrolled

Neural Mechanisms of Change During the Treatment of Alcohol Use Disorders With Prazosin

Completed·UUniversity of New Mexico·N/A·NCT01916941·36 enrolled

Modafinil for the Treatment of Alcohol Use Disorders

Completed·TThe Mind Research Network·Phase 2·NCT03424681·12 enrolled

Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home

Completed·NNorthwell Health·Phase 1/2·NCT02885311·27 enrolled

Development of Ivermectin for Alcohol Use Disorders

Completed·UUniversity of California, Los Angeles·Phase 1/2·NCT02046200·11 enrolled

Topiramate Treatment of Alcohol Use Disorders in African Americans

Terminated·VVA Office of Research and Development·Phase 4·NCT03018704·79 enrolled

Oxytocin Treatment for Alcohol Use Disorders

Withdrawn·UUniversity of North Carolina, Chapel Hill·Phase 2·NCT03636555

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)